• 

  Phil’s Journal: Another Alzheimer’s Drug, Lecanemab, Wins Early Approval—So, What Now?
• 

  Lecanemab Approved: New Disease-Modifying Alzheimer’s Drug Leqembi on the Market
• 

  Beyond the Hype: What Does the Lecanemab News Mean for People with Alzheimer’s?
• 

  CTAD: Lecanemab On Track to File for FDA Approval In Early 2023
• 

  Second Death Linked to Alzheimer’s Leqembi in Trial Extension
• 

  FDA Fast-Tracks Alzheimer’s Drug Lecanemab; Decision Expected By Early 2023
• 

  Eisai Seeks Accelerated Approval for Alzheimer’s Drug Lecanemab
• 

  FDA Speeds Up Process for Two More Anti-Amyloids

Previous23